IMMUNOLIGHT Trademark

Trademark Overview

On Tuesday, March 15, 2022, a trademark application was filed for IMMUNOLIGHT with the United States Patent and Trademark Office. The USPTO has given the IMMUNOLIGHT trademark a serial number of 97312589. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 26, 2024. This trademark is owned by IMMUNOLIGHT, LLC. The IMMUNOLIGHT trademark is filed in the Pharmaceutical Products category with the following description:

cancer treatment preparations; treatment preparations for autoimmune disorders
immunolight

General Information

Serial Number97312589
Word MarkIMMUNOLIGHT
Filing DateTuesday, March 15, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements

Goods and Servicescancer treatment preparations; treatment preparations for autoimmune disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIMMUNOLIGHT, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDetroit, MI 48226
Party NameIMMUNOLIGHT, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDetroit, MI 48226

Trademark Events

Event DateEvent Description
Monday, March 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 18, 2022NEW APPLICATION ENTERED
Wednesday, November 2, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 2, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 27, 2022ASSIGNED TO EXAMINER
Tuesday, December 27, 2022NON-FINAL ACTION WRITTEN
Tuesday, December 27, 2022NON-FINAL ACTION E-MAILED
Tuesday, December 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 29, 2023ASSIGNED TO LIE
Wednesday, March 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 29, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 29, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 2, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 26, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 26, 2023SOU EXTENSION 1 FILED
Tuesday, December 26, 2023SOU EXTENSION 1 GRANTED
Thursday, December 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 26, 2024SOU EXTENSION 2 FILED
Wednesday, June 26, 2024SOU EXTENSION 2 GRANTED

Related Keywords

immunolight treatment preparations disorders autoimmune cancer